Skip to main content
. 2020 Dec 22;14(1):3. doi: 10.3390/ph14010003

Figure 1.

Figure 1

A schematic display of the PD-1, PD-L1 and CTLA-4 pathway and its effects on the human immune cells in the tumor microenvironment. The boxes display the therapeutic options clustered per site of action.